 |
Codagenix
Last updated: August 02, 2024
Founders: J. Robert Coleman, Eckard Wimmer, Steffen Mueller
USA | Funding: $65.6M (+)
Website: http://codagenix.com/
Codagenix employs a proprietary technology platform for the construction of live attenuated viral vaccines for flu and other targets.
Website: http://codagenix.com/
Codagenix employs a proprietary technology platform for the construction of live attenuated viral vaccines for flu and other targets.
